Can Kellogg Company (NYSE:K) Maintain Its Strong Returns?




  • In Business
  • 2023-01-28 14:03:32Z
  • By Simply Wall St.
 

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. By way of learning-by-doing, we'll look at ROE to gain a better understanding of Kellogg Company (NYSE:K).

Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Simply put, it is used to assess the profitability of a company in relation to its equity capital.

Check out our latest analysis for Kellogg

How To Calculate Return On Equity?

Return on equity can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Kellogg is:

32% = US$1.5b ÷ US$4.7b (Based on the trailing twelve months to October 2022).

The 'return' refers to a company's earnings over the last year. Another way to think of that is that for every $1 worth of equity, the company was able to earn $0.32 in profit.

Does Kellogg Have A Good ROE?

By comparing a company's ROE with its industry average, we can get a quick measure of how good it is. However, this method is only useful as a rough check, because companies do differ quite a bit within the same industry classification. Pleasingly, Kellogg has a superior ROE than the average (14%) in the Food industry.

That's clearly a positive. Bear in mind, a high ROE doesn't always mean superior financial performance. Aside from changes in net income, a high ROE can also be the outcome of high debt relative to equity, which indicates risk. To know the 2 risks we have identified for Kellogg visit our risks dashboard for free.

Why You Should Consider Debt When Looking At ROE

Virtually all companies need money to invest in the business, to grow profits. That cash can come from issuing shares, retained earnings, or debt. In the first two cases, the ROE will capture this use of capital to grow. In the latter case, the use of debt will improve the returns, but will not change the equity. That will make the ROE look better than if no debt was used.

Kellogg's Debt And Its 32% ROE

It's worth noting the high use of debt by Kellogg, leading to its debt to equity ratio of 1.44. There's no doubt the ROE is impressive, but it's worth keeping in mind that the metric could have been lower if the company were to reduce its debt. Debt does bring extra risk, so it's only really worthwhile when a company generates some decent returns from it.

Conclusion

Return on equity is a useful indicator of the ability of a business to generate profits and return them to shareholders. A company that can achieve a high return on equity without debt could be considered a high quality business. All else being equal, a higher ROE is better.

But when a business is high quality, the market often bids it up to a price that reflects this. It is important to consider other factors, such as future profit growth -- and how much investment is required going forward. So you might want to check this FREE visualization of analyst forecasts for the company.

Of course Kellogg may not be the best stock to buy. So you may wish to see this free collection of other companies that have high ROE and low debt.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

ZoomInfo Technologies Inc.
ZoomInfo Technologies Inc.'s (NASDAQ:ZI) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

ZoomInfo Technologies (NASDAQ:ZI) has had a rough three months with its share price down 19%. However, stock prices are...

Is Weakness In Zimplats Holdings Limited (ASX:ZIM) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Is Weakness In Zimplats Holdings Limited (ASX:ZIM) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

It is hard to get excited after looking at Zimplats Holdings' (ASX:ZIM) recent performance, when its stock has declined...

Declining Stock and Decent Financials: Is The Market Wrong About Peet Limited (ASX:PPC)?
Declining Stock and Decent Financials: Is The Market Wrong About Peet Limited (ASX:PPC)?

It is hard to get excited after looking at Peet's (ASX:PPC) recent performance, when its stock has declined 4.3% over...

Are Strong Financial Prospects The Force That Is Driving The Momentum In Australian Clinical Labs Limited
Are Strong Financial Prospects The Force That Is Driving The Momentum In Australian Clinical Labs Limited's ASX:ACL) Stock?

Most readers would already be aware that Australian Clinical Labs' (ASX:ACL) stock increased significantly by 22% over...

Will Weakness in Ambertech Limited
Will Weakness in Ambertech Limited's (ASX:AMO) Stock Prove Temporary Given Strong Fundamentals?

It is hard to get excited after looking at Ambertech's (ASX:AMO) recent performance, when its stock has declined 22...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

  • Erussymer
    (2023-03-16 23:22:42Z)

    DMBA was then withdrawn, and daily treatments continued for a total of approximately 52 weeks cialis cheapest online prices

    REPLY

Top News: Business